Skip to main content
. 2017 Jun 28;8(53):90948–90958. doi: 10.18632/oncotarget.18770

Figure 2. Overall survival according to PIK3CA mutation status in cohort 2.

Figure 2

In cohort 2, overall survival was not significantly different between patients with PIK3CA-mutant tumors (black) and those with PIK3CA wild-type tumors (gray) (p = 0.416).